期刊文献+

间期荧光原位杂交技术检测骨髓增生异常综合征-7/7q-染色体异常的价值 被引量:2

Detection of-7/7q-chromosome abnormality in myelodysplastic syndromes by interphase fluorescence in situ hybridization
下载PDF
导出
摘要 目的探讨应用间期荧光原位杂交(FISH)技术检测7号染色体/7号染色体长臂缺失(-7/7q-)异常在骨髓增生异常综合征(MDS)中的价值。方法采用常规细胞遗传学(CC)和间期FISH检测技术对72例MDS患者和8例正常对照者的骨髓细胞进行分析,比较CC和FISH检测-7/7q-异常的情况。结果 72例MDS中,12例CC检测阳性,发生率16.7%。间期FISH检测24例阳性,发生率33.3%。两种方法检出率有统计学差异(P<0.05)。结论间期FISH技术敏感性高于CC,并能发现和纠正CC分析中的漏检异常。 Objective To investigate the value of detecting the monosomy 7 deletion(-7/7q-) using fluorescence in situ hybridization(FISH) in patients with myelodysplastic syndromes(MDS).Methods Common cytogenetics(CC) and interval FISH methods were used to analyzed the bone marrow cells in 72 cases of MDS patients and etght normal controls,and compared with their-7/7q-chromosome abnormality.Results Using CC,12 patients(16.7%) with-7/7q-in 72 case of MDS patients were found.However,24 patients(33.3%) with-7/7q-were found using FISH.There was significant difference between the two methods in detecting abnormal karyotypes in MDS(P0.05).Conclusions Interval FISH method is more sensitive for detection than CC,and can find and lower the rate of examine leakage of CC method.
出处 《山东医药》 CAS 北大核心 2010年第45期24-25,共2页 Shandong Medical Journal
基金 江苏省"六大人才高峰"第五批高层次人才资助项目 南通市科技应用研究项目(K2008032)
关键词 骨髓增生异常综合征 原位杂交 荧光 染色体障碍 myelodysplastic syndromes situ hybridization fluorescence chromosome disorders
  • 相关文献

参考文献6

  • 1Shaffer LG,Tommerup N.An international system for human cytoge-netic nomenclature[]..2005
  • 2Hasse D,Germing U,Schanz J,et al.Newinsights into the prognos-tic impact of the karyotype in MDS and correlation with subtypes:ev-idence froma core dataset of 2124 patients[].Blood.2007
  • 3Olney HJ,Le Beau MM.The cytogenetics of myelodysplastic syndromes[].Bailliere s Best Practice and Research Clinical Haematology.2001
  • 4ARIF M,TANAKA K,DAMODARAN C,et al.Hidden monosomy7in acute myeloid leukemia and myelodysplastic syndrome detected byinterphase fluo-rescence in situ hybridization[].Leukemia Research.1996
  • 5Tripputi P,Cassani B,Alfano R,et al.Chromosome 7 monosomy and deletions in myeloproliferative diseases[].Leukemia Research.2001
  • 6Brunning RD,Bennett JM,Flandrin G,et al.Myelodysplastic syndromes[].World Health Organization classification of tumoursPathology&genetics Tumours of haematopoietic and lymphoid tissues.2001

同被引文献27

  • 1Haase D. Cytogenetic features in myelodysplastic syndromes[-J].Ann Hematol, 2008,87 (7) 515-526.
  • 2Raza A,Galili N. The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes[J. Nat Rev Cancer, 2012, 12 (12) : 849-859.
  • 3何涛.33例骨髓增生异常综合征的染色体核型分析[J].2012,33(1):2123.
  • 4徐卫,李建勇.骨髓增生异常综合征的细胞和分子遗传学[J].国际输血及血液学杂志,2008,31(3),195-198.
  • 5Kawankar N, Vundinti BR. Cytogenetic abnormalities in myelo- dysplastic syndrome: an overviewFJ. Hematology, 2011,16 (3) : 131-138.
  • 6Garcia-Manero G. Prognosis of myelodysplastic syndromes [J]. Hematology Am Soc Hematol Edue Program, 2010, 2010(1): 330-337.
  • 7Tefferi A, Vardiman JW. Myelodysplastic syndromes [J]. N Engl J Med, 2009, 361(19): 1872-1885.
  • 8Haase D. Cytogenetic features in myelodysplastic syndromes [J]. Ann Hematol, 2008, 87(7): 515-526.
  • 9Raza A, Galili N. The genetic basis of phenotypic heterogeneity in myelodysplastic syndromes[J]. Nat Rev Cancer, 2012, 12(12): 849-859.
  • 10Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes [J]. Blood, 2009, 114(5): 937-951.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部